Cargando…
Serum Activities of Paraoxonase 1 (PON1) in Predicting Liver Damage Among Patients Diagnosed With Hepatocellular Carcinoma: A Case-Control Study
Introduction Hepatocellular carcinoma (HCC) is one of the most common cancers in the world and unless diagnosed timely has limited options for treatment. Paraoxonase (PON) is a glycosylated protein that has been implicated in antioxidant and other biochemical functions. Paraoxonase 1 (PON1) is an es...
Autores principales: | Bade, Jyotchna D, Veeramalla, Vydehi, Naidu, M Balachandra R, Lalitha, Danturty L, Ponnada, Sarath Chandra, Kandi, Venkataramana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613574/ https://www.ncbi.nlm.nih.gov/pubmed/37908943 http://dx.doi.org/10.7759/cureus.46234 |
Ejemplares similares
-
Taeniasis Presenting as Motile Worms in the Stools: An Emerging but Neglected Parasitic Disease
por: Kandi, Venkataramana, et al.
Publicado: (2022) -
Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014) -
Alzheimer’s Disease and Paraoxonase 1 (PON1) Gene Polymorphisms
por: Saeidi, Mohsen, et al.
Publicado: (2017) -
Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
por: Reichert, Cadiele Oliana, et al.
Publicado: (2019) -
Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis
por: Riedmaier, Stephan, et al.
Publicado: (2011)